Vildagliptin alleviates liver fibrosis in NASH diabetic rats via modulation of insulin resistance, oxidative stress, and inflammatory cascades

Theodor Bilharz Research Institute

Bibliographic Information

Authors: Hendawy A.S.; El-Lakkany N.M.; Mantawy E.M.; Hammam O.A.; Botros S.S.; El-Demerdash E.

Journal: Life Sciences

Publisher: Elsevier Inc.

Publication Date: September 2022

Volume / Issue: Volume 304

Article No.: 120695

ISSN: 243205

DOI: 10.1016/j.lfs.2022.120695

Scopus: View on Scopus

PubMed: 35671811

Document Type: Article


Authors and Affiliations

Hendawy A.S., Department of Pharmacology, Theodor Bilharz Research Institute, Kornaish El Nile, Warrak El-Hadar, Imbaba, 30, Giza, 12411, Egypt; El-Lakkany N.M., Department of Pharmacology, Theodor Bilharz Research Institute, Kornaish El Nile, Warrak El-Hadar, Imbaba, 30, Giza, 12411, Egypt; Mantawy E.M., Department of Pharmacology & Toxicology, Faculty of Pharmacy, Ain Shams University, Organization of African Unity Street, Abbasia, Cairo, 11566, Egypt; Hammam O.A., Department of Pathology, Theodor Bilharz Research Institute, Kornaish El Nile, Warrak El-Hadar, Imbaba, 30, Giza, 12411, Egypt; Botros S.S., Department of Pharmacology, Theodor Bilharz Research Institute, Kornaish El Nile, Warrak El-Hadar, Imbaba, 30, Giza, 12411, Egypt; El-Demerdash E., Department of Pharmacology & Toxicology, Faculty of Pharmacy, Ain Shams University, Organization of African Unity Street, Abbasia, Cairo, 11566, Egypt


Abstract

Aims: This study investigates the therapeutic potential of Vilda in a NASH model with liver fibrosis and elucidates the underlying molecular mechanisms. Main methods: To induce NASH, male Sprague-Dawley rats were fed a high-fat diet for 24 weeks with a single dose of STZ (40 mg/kg, IP). Vilda was orally administered at two doses (10 and 20 mg/kg) for 20 weeks. Key findings: The induction of NASH was validated by abnormalities in hepatotoxicity indices, lipid profile, oxidative stress markers, and pathologically by marked fat deposition in hepatic tissues together with severe inflammatory cell infiltration. Moreover, NASH-affected rats demonstrated reduced insulin sensitivity manifested as elevated fasting blood glucose levels and disrupted homeostasis model assessment for insulin resistance. Vilda, at both doses, effectively abrogated all these pathological features of NASH. Mechanistically, these hepatoprotective properties of Vilda can be attributed to its antioxidant effects, anti-inflammatory effects (by inhibiting the TNF-α, NF-κB, JNK, and JAK/STAT pathways), and insulin-sensitizing effect (by upregulating the IRS-1/PI3K/Akt pathway). Besides, Vilda successfully counteracted NASH-associated liver fibrosis by downregulating the TGF-β1 pathway. Significance: The hepatoprotective and antifibrotic effects of Vilda were mostly dose-dependent. Collectively, this study offered a promising therapeutic avenue for Vilda as a novel strategy for counteracting the pathological progression of NASH and associated liver fibrosis. © 2022 Elsevier Inc.


Keywords

Inflammation; Insulin resistance; Liver fibrosis; Nonalcoholic steatohepatitis; Type 2 diabetes; Vildagliptin; Animals; Diabetes Mellitus, Experimental; Diet, High-Fat; Insulin; Liver; Liver Cirrhosis; Male; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Phosphatidylinositol 3-Kinases; Rats; Rats, Sprague-Dawley; alanine aminotransferase; albumin; aspartate aminotransferase; bilirubin; catalase; glutathione; high density lipoprotein cholesterol; hydroxyproline; immunoglobulin enhancer binding protein; interleukin 6; Janus kinase; low density lipoprotein cholesterol; malonaldehyde; serum albumin; STAT3 protein; streptozocin; thiopental; transforming growth factor beta1; triacylglycerol; tumor necrosis factor; phosphatidylinositol 3 kinase; adult; anesthesia; animal experiment; animal model; animal tissue; antiinflammatory activity; antioxidant activity; Article; bilirubin blood level; cell infiltration; colorimetry; controlled study; diabetes mellitus; enzyme activity; glucose blood level; high fat/high sucrose diet; histopathology; homeostasis; immunohistochemistry; insulin blood level; insulin sensitivity; insulin signaling; JAK-STAT signaling; lipid diet; lipid fingerprinting; liver protection; liver toxicity; nonhuman; Pi3K/Akt signaling; rat; TGF beta signaling; adverse event; animal; complication; experimental diabetes mellitus; metabolism; nonalcoholic fatty liver; Sprague Dawley rat


Citation Information

Scopus Citations: 27


For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.

The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.

English Website: https://www.tbri.sci.eg/en/

Arabic Website: https://www.tbri.sci.eg/ar/

Prepared and Uploaded by:

Abdalla F. Abdalla

Electronic Portal Unit

Electronic Portal Unit

Popular Posts

A cost-performance index for nano-optical biosensor evaluation: Systematic evaluation of europium–salicylate luminescent platforms for GPC3-targeted early HCC diagnosis

Interpretation of liver stiffness measurement in patients with mixed liver disease etiologies

Variable clinical presentations of pulmonary hydatid cysts: a four-case series from a single center in United Arab Emirates, non-endemic region

Mytilus edulis-mediated green synthesis of selenium nanoparticles with antimicrobial and molluscicidal applications

Holothuria arenicola Extract-Loaded Polycaprolactone Nanocapsules Attenuate Bile Duct Ligation-Induced Acute Liver Injury

Microbial levan potentiates hepatic retention and antitumor activity of a PEGylated benzimidazole–curcumin nanocomplex through TLR2–FXR/FGF15-associated immunometabolic remodeling in experimental liver cancer

Corrigendum to ‘Eco-friendly approach for the removal and simultaneous detection of cyanide toxins from drinking and wastewater sources’ [Environ. Pollut. 385 (2025) 127094]